Drosophila inhibitor of apoptosis (IAP) 1 (DIAP1) is an E3 ubiquitin ligase that regulates apoptosis in flies, in large part through direct inhibition and/or ubiquitinylation of caspases. IAP antagonists, such as Reaper, Hid, and Grim, are thought to induce cell death by displacing active caspases from baculovirus IAP repeat domains in DIAP1, but can themselves become targets of DIAP1-mediated ubiquitinylation. Herein, we demonstrate that Grim self-associates in cells and is ubiquitinylated by DIAP1 at Lys136 in an UbcD1-dependent manner, resulting in its rapid turnover. K48-linked ubiquitin chains are added almost exclusively to BIR2-bound Grim as a result of its structural proximity to DIAP1's RING domain. However, active caspases can simultaneously cleave Grim at Asp132, removing the lysine necessary for ubiquitinylation as well as any existing ubiquitin conjugates. Cleavage therefore enhances the stability of Grim and initiates a feed-forward caspase amplification loop, resulting in greater cell death. In summary, Grim is a caspase substrate whose cleavage promotes apoptosis by limiting, in a target-specific fashion, its ubiquitinylation and turnover by the proteasome.
A poptosis, or programmed cell death, is broadly conserved throughout nature, from flies to humans (1) . In most instances, the execution of apoptosis is carried out by cysteinyl aspartatespecific proteases (i.e., caspases) through proteolytic-based signal transduction pathways (2) . Upstream initiator caspases, such as caspase-9 in humans and its paralogue Drosophila Nedd2-like caspase (DRONC) in flies, are first activated via their interactions with adapter proteins and in turn activate the downstream effector caspases, caspase-3 and Drosophila interleukin-1β-converting enzyme (DrICE), respectively (2, 3) . Once activated, effector caspases are responsible for dismantling the cell through cleavage of literally hundreds of structural and regulatory proteins (4) . Caspase cleavage can inactivate proteins or generate dominant-negative inhibitors, as in the case of gelsolin, RIP1, and eIF4E-BP1 (4) . Moreover, caspase cleavage of numerous substrates, including IRF-3, ErbB2, cyclin E, claspin, SSRP1, and Twist, can enhance their turnover by the proteasome (5) (6) (7) (8) (9) (10) . Conversely, caspases can also constitutively activate proteins, particularly kinases such as PKC and Mst1 (11, 12) , or change the function of a protein altogether, as seen in the conversion of antiapoptotic BCL-2 proteins into proapoptotic BAX-like proteins (13) .
Notably, even following the activation of caspases, inhibitor of apoptosis (IAP) proteins, such as X-linked IAP (XIAP) in mammals and DIAP1 in flies, can suppress apoptosis through inhibition of caspases (14) (15) (16) (17) (18) (19) . All IAPs contain baculovirus IAP repeat (BIR) domains and many possess RING and UBA domains, imparting them with E3 ubiquitin and NEDD8 ligase activity and the ability to bind polyubiquitin chains (20, 21) . Thus, XIAP and DIAP1 directly bind and inhibit, ubiquitinylate, and/or neddylate initiator and effector caspases through distinct BIR domains (15, 16, 19, (22) (23) (24) . In some circumstances, ubiquitinylation marks these enzymes for proteasomal degradation, whereas, in other cases, K63-based ubiquitinylation or neddylation fail to increase protein turnover but nevertheless inhibit protease activity through as yet ill-defined mechanisms (22, (25) (26) (27) ).
Finally, a further level of regulation exists in the form of endogenous inhibitors of IAPs. These so-called "IAP antagonists" possess an IAP binding motif (IBM) through which they bind to IAPs and disrupt their interactions with caspases (28) . Reaper, Hid, and Grim were the first IAP antagonists to be discovered in flies and were shown to regulate cell death during development, at least in part, by binding to DIAP1, displacing caspases, and inducing autoubiquitinylation and turnover of DIAP1 (18, 19, (29) (30) (31) (32) (33) (34) (35) . In the present study, we have discovered that DIAP1, in conjunction with the E2 ubiquitin-conjugating enzyme UbcD1, polyubiquitinylates Grim through K48-but not K63-based linkages, resulting in increased Grim turnover. Grim self-associates in cells and binds to both the BIR1 and BIR2 domains in DIAP1, but only the BIR2-bound Grim is significantly ubiquitinylated by DIAP1 in a RING-dependent manner. More surprisingly, Grim is also cleaved by caspases at its C terminus, removing the only lysine residue present in this IAP antagonist. Following caspase cleavage, Grim still binds to DIAP1 but is no longer ubiquitinylated and therefore persists in cells, propagating the death signal through increased activation of caspases.
Results
Grim Is Cleaved by Caspases at Asp132 During Apoptosis. In an experiment designed to characterize the putative IBM-independent effects of Grim (36), we cloned Grim with an N-terminal Flag tag to block access to its IBM. The tag however was initially cloned in-frame with the normal initiator methionine in Grim (i.e., Flag-MAIAY-Grim), and when expressed, two bands were unexpectedly observed (Fig. 1A, lane 3) . Importantly, the lower band disappeared in cells pretreated with the polycaspase inhibitor zVAD-fmk, so that only the upper band was observed (Fig. 1A, lane 4) . As we immunoblotted for Grim by using antibodies to the N-terminal Flag tag, this strongly suggested that Grim was cleaved at its C terminus by a caspase, and, indeed, endogenous DrICE was activated by Flag-MAIAY-Grim and inhibited by zVAD-fmk (Fig. 1A, lanes 3 and 4) .
Given that Grim requires its exposed IBM to displace active caspases from DIAP1, we questioned whether the Flag-MAIAYGrim construct might have undergone alternative translation from two different start sites, so that untagged MAIAY-Grim was produced in addition to Flag-MAIAY-Grim (Fig. 1B) . We reasoned that if IBM-competent AIAY-Grim activated caspases, they might in turn cleave the C terminus of Flag-MAIAY-Grim, yielding two Flag-tagged products (Fig. 1B) . To test this prediction, we first removed the internal methionine from our Flag-MAIAY-Grim construct and transfected cells with Flag-AIAY-Grim. As anticipated, expression of Flag-AIAY-Grim resulted in a single translated product that failed to activate caspases or undergo cleavage (Fig. 1A, compare lanes 1 and 3) . Second, we transfected cells with Flag-AIAY-Grim and exposed them to the translation inhibitor cycloheximide (CHX), a known inducer of apoptosis in S2 cells (37) . As expected, CHX induced (and zVAD-fmk inhibited) the activation of DrICE and the subsequent cleavage of Flag-AIAYGrim at its C terminus (Fig. 1C, lanes 3 and 4) .
Having demonstrated that Grim is cleaved by caspases, we next sought to identify the caspases responsible for cleavage. Grim is thought to promote DARK-DRONC apoptosome-mediated activation of effector caspases, such as DrICE, by antagonizing DIAP1-dependent turnover of DRONC. Therefore, we knocked down the expression of DRONC or DrICE in S2 cells by RNAi and found that depletion of either caspase inhibited the cleavage of Flag-MAIAY-Grim (Fig. 1D) . Notably, whereas knockdowns of DrICE and particularly DRONC appeared to be near-complete, zVAD-fmk inhibited Grim cleavage more efficiently than knockdown of either caspase. Thus, we cannot formally exclude the possibility that other caspases are involved in the cleavage of Grim.
Finally, to map the caspase cleavage site(s) in Grim, we examined its C terminus and noted the presence of two potential DXXD motifs, DEDD 129 and DVTD
132
, both of which were followed by small uncharged amino acids (valine and alanine, respectively) in the P 1 ′ position (Fig. 1B) . We suspected the cleavage site was DVTD 132 ↓A because of the more preferable P 2 amino acid, but feared that mutation of Asp132 to alanine might redirect some cleavage to Asp129. Therefore, we incorporated a single D132A or a compound D129A/D132A mutation into the Flag-MAIAYGrim construct and expressed the mutants in S2 cells. As shown in Fig. 1E , mutation of Asp132 alone inhibited the C-terminal cleavage of Grim (Fig. 1E , compare lane 3 with lanes 1 and 2). Thus, Grim (via its IBM) antagonizes DIAP1 and activates caspases, which in turn cleave Grim at Asp132 to liberate its C terminus (Fig. 1B) .
DIAP1 Ubiquitinylates Grim at a Single Lysine Residue That Is Removed by Caspases. As previously noted, IAP antagonists can be ubiquitinylated by IAPs (38) (39) (40) (41) , and, while mapping the caspase cleavage site for Grim, we noted the presence of a single lysine, located downstream of the caspase cleavage site (Fig. 2A) . This led us to question whether DIAP1 ubiquitinylated Grim at Lys136 in cells and ultimately whether removal of its C terminus could protect Grim from proteasomal-mediated degradation ( Fig. 2A) . Although the usefulness of our Flag-MAIAY-Grim construct was immeasurable in initially revealing Grim cleavage (Fig. 1) , its processing was somewhat complicated in that Flag-MAIAY-Grim could not interact with DIAP1, and AIAY-Grim could not be detected with an anti-Flag antibody. Therefore, moving forward, we chose instead to use a Grim-HSV construct, as it contained a fully functional IBM, capable of binding DIAP1 (as detailed later), and, unlike Flag, the HSV tag did not contain a lysine residue to interfere with our ubiquitinylation studies. Of course, Grim cleavage prevented us from visualizing HSV with an anti-HSV antibody, but this could be easily overcome by mutating Asp132 to alanine.
Importantly, when coexpressed with DIAP1 or DIAP2, Grim (D132A) underwent time-dependent ubiquitinylation that was not observed with Grim (D132A/K136R) [henceforth known as Grim (DA/KR); Fig. 2 B and C] . DIAP1 coexpression improved our detection of Grim-ubiquitin conjugates, and we were careful to express proportional amounts of DIAP1 and Grim (Fig. S1 ), but the Grim-ubiquitin conjugates could still be immunoprecipitated from cell lysates expressing only Grim and Flag-ubiquitin (Fig. 2D ). Consistent with these data, in pulse-chase experiments, Grim (D132A) was rapidly degraded (t 1/2 < 2 h) in cells, whereas Grim (DA/ KR) was resistant to turnover (t 1/2 > 8 h; Fig. 2E , lanes 1-10). Treatment with the proteasomal inhibitor MG132 also resulted in the accumulation of Grim (D132A) and its ubiquitinylated species in the presence and absence of ectopically expressed DIAP1 ( . Thus, DIAP1 mediates the turnover of Grim by ubiquitinylating it on Lys136, but turnover can be suppressed by caspase cleavage at Asp132 without disrupting its interaction with DIAP1.
Grim Self-Associates and Is Ubiquitinylated by DIAP1 in a BIR2 and RING-Dependent Manner. To further characterize the mechanisms of Grim ubiquitinylation, we next examined several DIAP1 mutants ( Fig. 3A) and did so in the presence of zVAD-fmk to prevent cell death without interfering with Grim ubiquitinylation (Fig. 2F , lanes 2 and 6). As expected, removal of the RING domain from DIAP1-or introduction of a RING mutation into full-length DIAP1-prevented Grim ubiquitinylation entirely (Fig. 3B , lanes 5 and 6, and Fig. 3C, lanes 3 and 4) . Surprisingly, however, a BIR2-RING fragment was approximately equal to full-length DIAP1 at ubiquitinylating Grim (Fig. 3B , compare lanes 3, 4, 7, and 8), and a BIR2 mutation (H283Y) in full-length DIAP1 or the BIR2-RING fragment diminished or abolished Grim ubiquitinylation altogether (Fig. 3C , lanes 7 and 8, and Fig.  3D , lanes 3 and 4). A BIR1 mutation (W90A), on the contrary, had no significant impact on Grim ubiquitinylation (Fig. 3C , compare lanes 1, 2, 5, and 6), but, when combined with the BIR2 mutation, DIAP1 (W90A/H283Y) was largely defective in its Following treatment, cell lysates were prepared and immunoblotted for Flag-tagged Grim or endogenous DrICE. (D) S2 cells were treated with dsRNA to human TNF (control), DrICE, or DRONC for 24 h, followed by transfection with pIE-Flag-MAIAY-Grim. As a positive control, cells were also treated with zVAD-fmk (50 μM) to inhibit caspases and prevent Grim cleavage. (E) pIEFlag-MAIAY-Grim, which undergoes C-terminal cleavage, was mutated at Asp132 or Asp129/Asp132 and transfected into S2 cells. pIE-Flag-AIAY-Grim was used as a positive control, as it does not undergo alternative translation or C-terminal cleavage. After 24 h, cell lysates were prepared and immunoblotted for Flag-tagged Grim and endogenous DrICE.
ability to bind and ubiquitinylate Grim (Fig. 3E , lanes 2 and 7, and Fig. 3D, lanes 7 and 8) .
The fact that a BIR2 mutant negatively impacted Grim ubiquitinylation more than a BIR1 mutant, even though Grim binds to BIR1 with higher affinity (19, 28) , suggested that the proximity of Grim to the RING domain affected Grim ubiquitinylation more so than differences in binding affinity. To test this hypothesis, we generated a ΔBIR2 fragment (Fig. 3A) and found that this internal BIR2 deletion mutant ubiquitinylated Grim almost as efficiently as the BIR2-RING fragment (Fig. 3D, lanes  1, 2, 5, and 6 ). Interestingly, we also noted that incorporation of the H283Y mutation into full-length DIAP1 dramatically enhanced DIAP1 autoubiquitinylation, regardless of the BIR1 mutation (Fig.  3C, lanes 7 and 8, and Fig. 3D , lanes 7 and 8), but had little effect on the BIR2-RING fragment, which failed to undergo significant autoubiquitinylation (Fig. 3D, lanes 3 and 4) . Thus, DIAP1 preferentially ubiquitinylates BIR2-bound Grim, but in the absence of a BIR2-bound substrate, DIAP1 appears to ubiquitinylate itself somewhere in or around the BIR1 domain (Fig. 3G) .
Finally, we noted that, whereas ΔBIR2 (W90A) and BIR2-RING (H283Y) were fully defective in Grim binding, full-length DIAP1 (W90A/H283Y) retained a weakened but persistent interaction with Grim (Fig. 3E, lanes 2, 4, 6, and 7) . Recent studies suggest that some IAPs and IAP antagonists can homo-and heterodimerize (42) (43) (44) (45) (46) , leading us to speculate that a Grim dimer might form a more stable interaction with DIAP1 (W90A/H283Y) by forming simultaneous low-affinity interactions with BIR1 and BIR2. To determine if Grim could self-associate in cells, we coexpressed and immunoprecipitated differentially tagged IBM mutants of Grim [i.e., Grim (A2G/I3G)-HSV and Grim (A2G/I3G)-myc] and discovered that indeed Grim could self-associate (Fig. 3F, lane 3) , independently of its interaction with DIAP1 (Fig. 2E, compare  lanes 2 and 4) . Thus, we propose that Grim dimerizes and engages DIAP1 through interactions with its BIR1 and BIR2 domains, similar to the manner in which dimerized Smac interacts with XIAP (47), but only BIR2-bound Grim undergoes significant RING-dependent ubiquitinylation (Fig. 3G ).
Grim Is Polyubiquitinylated by DIAP1 and the E2 Ubiquitin-conjugating Enzyme UbcD1, Primarily Through K48-Linked Chains. Previous studies have suggested that Reaper and Grim-induced autoubiquitinylation of DIAP1 is mediated by the E2 ubiquitin-conjugating enzymes, Morgue and UbcD1, and that Grim catalyzes this process through direct binding to UbcD1 (33, 35, 48, 49 ). Therefore, to determine the roles of Morgue and UbcD1 in DIAP1-mediated ubiquitinylation of Grim, we performed knock down experiments in S2 cells and found that depletion of UbcD1, but not Morgue, significantly reduced polyubiquitinylation of Grim (Fig. 4A ). Because DIAP1 can catalyze both K48 and K63 ubiquitin linkages (25), we next sought to establish the type of linkages present in ubiquitinylated Grim. S2 cells were transfected with DIAP1, along with either Grim (D132A) or Grim (DA/KR), and, after 24 h, Grim proteins were isolated and immunoblotted with antibodies specific for endogenous K48 or K63-linked ubiquitin chains. Importantly, Grim (D132A), but not Grim (DA/KR), underwent DIAP1-dependent K48-linked ubiquitinylation (Fig. 4B , lanes 2 and 4), consistent with the observed turnover of Grim (Fig.  2E, lanes 1-10) and the accumulation of Grim-ubiquitin conjugates following treatment with MG132 (Fig. 2F, lanes 1, 2, 5 , and 6).
DrICE Removes the C Terminus from Grim-ubiquitin Conjugates and
Inhibits Grim Turnover. K48-linked ubiquitin chains of four or more were once thought to be essential for proteasome-mediated degradation of a substrate (50) . A more recent study, however, indicates that chain length requirements depend upon the size of the substrate, with smaller substrates requiring shorter chains (51) . In our experiments, we primarily observed Grim-ubiquitin chains of two to four ubiquitins in length (Grimubiquitin 2-4 ; Figs. 2, 3, and 4 A and B) . This was not a result of interference of the ubiquitin chains with the C-terminal tag, as extending the C terminus (3×HSV) failed to significantly improve our capture of higher-order Grim-ubiquitin n > 5 conjugates (Fig. S2) . Thus, the addition of four or fewer ubiquitins to Grim appears to be sufficient to mediate its turnover. We similarly questioned whether polyubiquitinylation of Grim at Lys136 might interfere with its caspase cleavage at Asp132. Therefore, we expressed Grim in S2 cells in the presence of zVAD-fmk, washed the cells, prepared lysates, and incubated them with or without recombinant DrICE in vitro. As expected, Grim (D132A) was ubiquitinylated, but neither the conjugated nor unconjugated forms were susceptible to DrICE cleavage (Fig.  4C, lanes 5 and 6) . Grim, Grim-ubiquitin conjugates, and Grim (K136R), on the contrary, underwent robust cleavage by DrICE (Fig. 4C, lanes 2 and 4) . Moreover, by using a recently available polyclonal antibody to Grim, we observed the appearance of a single N-terminal fragment of Grim (1-132), indicating that Grim and its ubiquitinylated species were cleaved by DrICE (Fig. 4C , Middle panel, lanes 2 and 4). Thus, DrICE can prevent proteasomal-mediated turnover of Grim and extend its t 1/2 in cells by removing its C terminus before or after ubiquitinylation.
Grim Cleavage and Ubiquitinylation Impact the Kinetics of Caspase
Activation and Cell Death. Finally, to determine the impact of caspase cleavage on Grim-induced caspase activation and cell death, we expressed Grim in S2 cells, measured DEVDase activity at 6 h, and used time-lapse DIC and fluorescence microscopy to quantify apoptosis. As expected, Grim (D132A) produced less caspase activity and cell death over time, compared with WT Grim, in agreement with the fact that noncleavable Grim is ubiquitinylated and degraded regardless of caspase activity (Fig.  5) . Conversely, Grim (K136R), Grim (DA/KR), and the N-terminal cleavage fragment Grim (1-131) could not be ubiquitinylated and therefore supported greater levels of caspase activation and cell death, particularly compared with noncleavable Grim (Fig. 5) . Thus, cleavage of Grim sustained its presence in the cell and facilitated a feed-forward caspase amplification loop, wherein cleaved Grim was allowed to continue its antagonism of DIAP1, thereby enhancing caspase activation and cell death.
Discussion
Caspases play an undeniable role in the progression of apoptosis, mediating the cleavage of numerous substrates (>800 in mammals) and the eventual dismantling of the cell (4). For certain substrates removal of a regulatory domain results in their constitutive activation, as in the case of various kinases (11, 12) . For others, cleavage results in a loss of function, and the resulting fragments are frequently degraded by the 26S proteasome (5) (6) (7) (8) (9) (10) . In this study, we found an interaction between caspases and the ubiquitin-proteasome system. Caspase cleavage of the IAP antagonist Grim, at its C terminus, removes a critical lysine before or following its ubiquitinylation by DIAP1. In doing so, caspases sustain the presence of Grim in the cell and allow it to further activate caspases by antagonizing additional DIAP1. Thus, in effect, caspases compete with the proteasome to determine the fate of Grim and, by extension, the fate of the cell. Most of the previous studies on Grim have focused on its acute cell death effects, with little consideration as to how this IAP antagonist is regulated at the posttranscriptional level. Grim plays a selective role in the death of glial cells in the microchaete of flies and in regulating the number of neuroblasts during development of the ventral nerve cord (52, 53) . However, there are examples in which spatiotemporal control of caspase activity is required to induce differentiation while preventing cell death. For example, caspases play important roles in spermatid individualization (54, 55) , and Grim is expressed in Malpighian tubules during metamorphosis, implying that it plays a role in the formation of these tubules, but its expression is largely restricted to the nucleus (56, 57) . Thus, the interplay among DIAP1, caspases, Grim, and the proteasome may constitute a unique form of rheostatic control, such that, at relatively low levels of Grim, DIAP1 may allow for some caspase activity while limiting through ubiquitinylation the overall levels of Grim and active caspases. In this model, as Grim expression reaches a threshold, the level of caspase activity becomes sufficient to liberate Grim's C terminus, thereby preserving its presence in the cell and further enhancing caspase activation.
The wider prevalence of an interaction between caspases and the ubiquitin-proteasome system will require further investigation in the future. However, a cursory examination of the UniProt/ Swiss-Prot database indicates that 197 proteins (including splice variants) contain a single lysine in their coding sequences, and a number of these proteins contain a predicted caspase cleavage site(s) that, if genuine, would liberate the lysine from the N or C terminus of the protein (Dataset S1). Moreover, proteins with multiple lysines need not be excluded from this list, as there are examples in which a particular lysine still represents the primary target for ubiquitinylation (58) . Although caspase cleavage of Grim enhances cell death, the preservation of other caspase substrates, such as transcription factors, could mediate nonapoptotic events, including differentiation. Finally, this type of regulation may not be restricted to caspases, as proteolytic removal of a key lysine could be performed by other proteases, including calpains and cathepsins, revealing novel interactions between these proteases and the ubiquitin-proteasome system.
Materials and Methods
Grim constructs were cloned into a pIE vector (Novagen) with an N-terminal Flag tag by using SacII-NotI sites or into a pRmHa3 vector with a C-terminal HSV-His 6 tag using EcoRI-NotI sites. DIAP1 and DIAP2 constructs were cloned into a pIE vector with an N-terminal HA, Flag, or GFP tag by using SacII-NotI sites. Constructs with Grim or DIAP1 point mutants were generated by using site-directed mutagenesis. Ubiquitin was cloned into a pMT vector (Life Technologies) by using KpnI-NotI sites with an N-terminal Flag tag. UbcD1 and Morgue constructs were cloned into a pIE vector with an N-terminal myc tag by using SacII-NotI sites.
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